Gene-Expression Assays and Personalized Cancer Care: Tissue-Of-Origin Test for Cancer of Unknown Primary Origin
- 26 July 2011
- journal article
- Published by Taylor & Francis in Personalized Medicine
- Vol. 8 (4) , 429-436
Abstract
Cancer of unknown primary (CUP) is one of the ten most frequently diagnosed cancers in developed countries and accounts for 3-5% of all new cancer cases. For all cancer management, chemotherapeutic regimens and targeted agents have increasingly become primary-site dependent over the last decade, and thus, accurate identification of the primary site is crucial for CUP patients. Histopathologic examination along with immunohistochemical studies and different imaging modalities are most often performed for this purpose, but still a significant number of patients remain with an unidentified primary. Recently, gene-expression profiling assays have emerged as alternative tests for tumor tissue of origin determination. It is expected that molecular determination of the origin in patients with CUP will aid in the determination of management strategies. It is thus possible that personalized treatment of CUP patients based on molecular classification could significantly improve patient outcomes.Keywords
Funding Information
- Pathwork Diagnostics
This publication has 34 references indexed in Scilit:
- Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded SpecimensThe Journal of Molecular Diagnostics, 2011
- Cancer of unknown primary site: 20 questions to be answeredAnnals of Oncology, 2010
- Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue originLaboratory Investigation, 2010
- Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2010
- Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin PredictionThe Oncologist, 2010
- MicroRNAs in Cancer: Small Molecules With a Huge ImpactJournal of Clinical Oncology, 2009
- MicroRNAs accurately identify cancer tissue originNature Biotechnology, 2008
- Switching benchmarks in cancer of unknown primary: From autopsy to microarrayEuropean Journal of Cancer, 2007
- Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cellsBMC Biotechnology, 2007
- Roadmap for Developing and Validating Therapeutically Relevant Genomic ClassifiersJournal of Clinical Oncology, 2005